The World Health Organization took steps to strengthen clinical trial design and implementation with an online course intended to support researchers globally, citing concerns about the integrity of evidence during a period where science faces political pressure. WHO highlighted “Good Practices for Clinical Trial Design and Implementation” and framed it as essential for trustworthy results and participant protection. WHO officials said the nine-module training covers ethical and scientific principles, trial conduct, oversight, and participant protection. The guidance also emphasizes inclusion of underrepresented groups such as children, pregnant women, and older adults. This WHO move aligns with broader calls to improve national clinical trial capabilities and compliance with international standards. For biotech, enhanced global trial quality support can influence how sponsor planning, oversight, and recruitment strategies are structured—especially across multi-region clinical development. In practical terms, the course may act as a harmonization tool for trial stakeholders operating where regulatory capacity and trial infrastructure vary widely.